Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations
View as a Web Page
News Medical
 
  Schizophrenia Schizophrenia logo  
  The latest schizophrenia news from News Medical  
 Trial shows potential benefit of ketogenic diet for treating psychotic disordersTrial shows potential benefit of ketogenic diet for treating psychotic disorders
 
Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders.
 
 
 Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populationsSemaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations
 
A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated weight-loss effect among GLP-1 receptor agonists tested in adults with mental illness and obesity or related metabolic risk. The authors cautioned that the findings remain preliminary because the evidence base was small, heterogeneous, and largely indirect.
 
   Rutgers study maps distinct patterns of brain connection loss in schizophreniaRutgers study maps distinct patterns of brain connection loss in schizophrenia
 
Research involving a Rutgers professor sheds new light on the biological basis of schizophrenia by directly measuring synaptic connections in the human brain using specialized positron emission tomography (PET) imaging.
 
 Motor abnormalities may predict multiple mental health disorders
 
Motor abnormalities may predict multiple mental health disordersMotor issues-such as coordination problems, motor slowing, or sudden, uncontrolled movements-have been recognized as signs of psychological disorders since the 1800s. How they map to mental health conditions, however, remains unknown.
 
 
 PET imaging reveals widespread brain receptor deficits in schizophrenia
 
PET imaging reveals widespread brain receptor deficits in schizophreniaA groundbreaking study using positron emission tomography (PET) imaging has found that patients with schizophrenia had significantly lower muscarinic acetylcholine M1 receptor availability (~13% to 19%) across multiple brain regions compared with healthy individuals.
 
 
 Experimental therapy helps brain cells bypass genetic deletions
 
Experimental therapy helps brain cells bypass genetic deletionsScientists at the Fralin Biomedical Research Institute at VTC have discovered how an experimental therapy can help brain cells overcome the effects of a disease-causing genetic deletion.
 
 
 ECT-like brain stimulation triggers unexpected nuclear reprogramming in mature neurons
 
ECT-like brain stimulation triggers unexpected nuclear reprogramming in mature neuronsNearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies such as ECT and Repetitive Transcranial Magnetic Stimulation (rTMS) are common in psychiatry because they are highly effective for treating depression and schizophrenia, yet their cellular mechanisms remain poorly understood
 
 
 Dementia addiction and psychiatric disorders show distinct patterns of accelerated brain aging
 
Dementia addiction and psychiatric disorders show distinct patterns of accelerated brain agingPeople with dementia, mild cognitive impairment, alcohol addiction, or psychiatric disorders such as schizophrenia show increased brain aging, each in specific patterns within the brain, according to a study published July 21st in the open access journal PLOS Medicine by Shile Qi from the Nanjing University of Aeronautics and Astronautics, China, and colleagues.
 
 
 Study reveals long-term, intergenerational impacts of severe preconception trauma
 
Study reveals long-term, intergenerational impacts of severe preconception traumaCan the trauma of a parent rewrite the mental health of a child born decades later? A new compelling study reveals that children born decades after the Holocaust to parents who were older than age five at the time of the initial Nazi persecutions faced elevated schizophrenia risk.
 
 
 Study provides a practical recall-by-genotype strategy for precision psychiatry research
 
Study provides a practical recall-by-genotype strategy for precision psychiatry researchClinical biobanks that combine genomic data with electronic health records (EHRs) have become powerful resources for discovering genetic variants associated with disease.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026